logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
BackJournal Details
Pharmacogenomics Journal cover

Pharmacogenomics Journal

IF2.9
Papers55
Citations2423
Journal Papers 42
Publication Date
delete
Real-world analysis of genotype-guided treatment for carriers of actionable DPYD and UGT1A1 variants
deletePharmacogenomics Journal
IF2.9
delete2026-10-12
delete0
deleteOAAI
deleteAmy L. Pasternak; William Tackett; Mousumi Banerjee; Simi Paul; Emily Bertucci-Richter; Xiang Zhou; Vaibhav Sahai; Daniel L. Hertz
deleteShare
deleteSave
Bridging the pharmacogenomics gap: a survey of healthcare workers in South-Western Nigeria
deletePharmacogenomics Journal
IF2.9
delete2026-10-05
delete0
PREAI
deleteOchuko M. Orherhe; Omolabake F. Ayodele; Jeremiah O. Omojuyigbe; Ayodapo O. Jegede; Olumide A. Alade; Kikelomo Oladimeji; Oluwatimilehin S. Ogunde; Promise U. Okereke; Oluwafemi O. Agboola; Moteehat O. Olu-Lawal; Olusanya Aluko; Babatunde A. Adeagbo; Oluseye O. Bolaji
deleteShare
deleteSave
The role of pharmacogenomics in epilepsy treatment: advancements in personalized medicine
deletePharmacogenomics Journal
IF2.9
delete2026-10-01
delete0
PREAI
deleteNajmeh Ahangari; Mohammad Doosti; Mojtaba Safi; Narges Hashemi; Shima Imannezhad; Bita Barazandeh; Ehsan Ghayoor Karimiani; Mehran Beiraghi Toosi
deleteShare
deleteSave
Risk of drug-induced liver injury in multiple system atrophy patients treated with KM-819 is potentially associated with the HLA-DPB1*05:01:01:01 allele
deletePharmacogenomics Journal
IF2.9
delete2026-09-28
delete0
deleteOAAI
deleteJeong-Hoon Han; Raúl J. Andrade; Einar Stefán Björnsson; James Hendricks Lewis; M. Isabel Lucena; Suyoung Go; Simona Stankeviciute; Guruprasad P. Aithal; Kyuchan Kim; Chong Sik Lee; Carrolee Barlow; Eunhee Kim
deleteShare
deleteSave
Barriers and facilitators to the implementation of pharmacogenomic testing for antidepressants use in primary care: a systematic review using the consolidated framework for implementation research
deletePharmacogenomics Journal
IF2.9
delete2026-09-09
delete0
PREAI
deleteMuireann Counihan; Deirdre Cushen; Sookyung Kwak; Amy Allen; Donnchadh Fitzsimons Mac Giolla Chuda; Weronika Romanska; Ibrahim Nakchbandi; Rose Reynolds; Chad Bousman; Mark Ledwidge; Joseph Gallagher; Cristín Ryan
deleteShare
deleteSave
Amplicon-based long-read sequencing for accurate CYP2D6 gene deletion and duplication detection using CYP2D7 as a reference gene
deletePharmacogenomics Journal
IF2.9
delete2026-08-26
delete0
deleteOAAI
deleteKiflu Gebremicael Tesfamicael; Michael Musker; David L. Adelson; Martin David Lewis
deleteShare
deleteSave
Association between CYP2D6 genotype and treatment effectiveness and safety in 99 hospitalized patients with major depressive disorder a retrospective cohort study CYP2D6 genotype and antidepressant response
deletePharmacogenomics Journal
IF2.9
delete2026-08-19
delete0
deleteOAAI
deleteAleksandra Petković Ćurčin; Aleksandra Jeremić; Danilo Joković; Gordana Šupić; Katarina Simić; Filip Milosavljević; Zvezdana Stojanović; Marin M. Jukić
deleteShare
deleteSave
Large-scale analysis demonstrates the influence of CYP2C19 genotype on specific SSRI side effects
deletePharmacogenomics Journal
IF2.9
delete2026-08-05
delete0
deleteOAAI
deleteChris Eijsbouts; Yunxuan Jiang; James R. Ashenhurst; Julie M. Granka; Steven Pitts; Adam Auton; Noura S. Abul-Husn; Alison Chubb; R. Ryanne Wu
deleteShare
deleteSave
Effects of CYP3A4, CYP3A5, and ABCB1 genetic variants on tacrolimus metabolism during the early period after kidney transplantation
deletePharmacogenomics Journal
IF2.9
delete2026-07-30
delete0
PREAI
deleteNahathai Dukaew; Kajohnsak Noppakun; Mingkwan Na Takuathung; Nattharinee Kongta; Ratchanon Inpan; Naruemon Suyayai; Nut Koonrungsesomboon
deleteShare
deleteSave
Understanding public perspectives on direct-to-consumer pharmacogenomic testing in the UK: a qualitative study
deletePharmacogenomics Journal
IF2.9
delete2026-07-25
delete0
deleteOAAI
deleteAmy Mathieson; Lisa Brunton; Stephanie Gillibrand; Ramona Moldovan; John H. McDermott
deleteShare
deleteSave
FTO rs7195994 Is associated with TNF inhibitor response in lean rheumatoid arthritis patients: A BMI-stratified pharmacogenetic analysis
deletePharmacogenomics Journal
IF2.9
delete2026-05-01
delete0
PREAI
deleteLi, Yi-Ting; Chen, I-Chieh; Yang, Hui-Wen; Kao, Chung-Mao; Chen, Yen-Ju; Huang, Wen-Nan; Chen, Yi-Ming
deleteShare
deleteSave
Association of folylpolyglutamate synthase polymorphisms with methotrexate response and toxicity in rheumatoid arthritis: a meta-analysis
deletePharmacogenomics Journal
IF2.9
delete2026-04-01
delete0
PREAI
deleteLee, Young Ho; Song, Gwan Gyu
deleteShare
deleteSave
A potential association of SLC2A9 variant rs7442295 with uric acid at baseline and in interaction with iloperidone
deletePharmacogenomics Journal
IF2.9
delete2026-03-13
delete0
deleteOAAI
deleteSmieszek, Sandra P.; Chadwick, Sean R.; Czeisler, Emily L.; Torres, Rosarelis; Bai, Haimeng; Xiao, Changfu; Polymeropoulos, Christos M.; Birznieks, Gunther; Polymeropoulos, Mihael H.
deleteShare
deleteSave
Computational variant predictors for pharmacogenomics: from evaluation of single alleles to assessment of adverse drug reactions to antidepressants
deletePharmacogenomics Journal
IF2.9
delete2026-03-09
delete0
deleteOAAI
deleteHajto, Jacek; Piechota, Marcin; Kratschmer, Ilse; Konowalska, Paula; Boyle, Gabriel E.; Fowler, Douglas M.; Borczyk, Malgorzata; Korostynski, Michal
deleteShare
deleteSave
STRIPE partners in precision medicine: international perspective
deletePharmacogenomics Journal
IF2.9
delete2026-03-05
delete0
PREAI
deleteKong, Ben L.; Esquivel, Bernard; Nagy, Mohamed; Patrinos, George P.; Jones, J. Shawn; Rogers, Sara L.
deleteShare
deleteSave
Antidepressant drug switching in the Swiss population with a focus on Escitalopram and drugs with pharmacogenetic dosing guidelines: a drug utilization study using claims data
deletepharmacogenomics journal
IF0
delete2025-08-08
delete0
deleteOAAI
deleteM. M. Roth; C. R. Meier; C. A. Huber; H. E. Meyer zu Schwabedissen; S. Allemann; C. Schneider
deleteShare
deleteSave
Benchmarking large language models for replication of guideline-based PGx recommendations
deletepharmacogenomics journal
IF0
delete2025-07-26
delete0
PREAI
deleteMike Zack; Ioan Slobodchikov; Danil Stupichev; Alex Moore; David Sokolov; Igor Trifonov; Allan Gobbs
deleteShare
deleteSave
Impact of low BMI and ABCC2 genotype on the clinical response of sequential anthracycline-taxane chemotherapy receiving breast cancer patients: a hospital-based study
deletepharmacogenomics journal
IF0
delete2025-07-16
delete0
PREAI
deleteTanuma Mistry; Sanghamitra Sengupta; R. Suresh Kumar; Nisha Thakur; Partha Nath; Neyaz Alam; Vilas D. Nasare
deleteShare
deleteSave
Correction: Integrating rare genetic variants into DPYD pharmacogenetic testing may help preventing fluoropyrimidine-induced toxicity
deletepharmacogenomics journal
IF0
delete2025-07-15
delete0
deleteOAAI
deleteRomain Larrue; Sandy Fellah; Benjamin Hennart; Naoual Sabaouni; Nihad Boukrout; Cynthia Van der Hauwaert; Clément Delage; Meyling Cheok; Michaël Perrais; Christelle Cauffiez; Delphine Allorge; Nicolas Pottier
deleteShare
deleteSave
Pharmacogenomic-guided opioid therapy for pain: a systematic review and meta-analysis of randomised controlled trials
deletepharmacogenomics journal
IF0
delete2025-07-12
delete0
PREAI
deleteS. Jethwa; M. Ball; K. Langlands
deleteShare
deleteSave